Adenoma Miss Rate With Water Exchange vs Carbon Dioxide Colonoscopy
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03832322 |
Recruitment Status :
Completed
First Posted : February 6, 2019
Results First Posted : May 10, 2019
Last Update Posted : May 21, 2019
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Colonic Adenoma Water Exchange Colonoscopy | Procedure: Water exchange colonoscopy Procedure: CO2 insufflation colonoscopy |
Study Type : | Observational |
Actual Enrollment : | 176 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Water Exchange Colonoscopy Decreased Adenoma Miss Rates in the Right and Proximal Colon: An Observational Study Using A Tandem Colonoscopy Approach |
Actual Study Start Date : | July 9, 2018 |
Actual Primary Completion Date : | November 28, 2018 |
Actual Study Completion Date : | November 28, 2018 |

Group/Cohort | Intervention/treatment |
---|---|
Water exchange colonoscopy
During the insertion phase of the first-pass colonoscopy, water exchange (WE) method was used. WE entailed the infusion of water to open the lumen and sequentially suction of water. When the cecum was reached and after most of the water was suctioned to collapse the cecal lumen, CO2 was opened during the withdrawal phase of the first-pass colonoscopy. After the first complete withdrawal of the colonoscope, a second colonoscopic examination aided by CO2 insufflation during insertion and withdrawal was performed by the same endoscopist. The colonoscope was reinserted into the cecum as quickly as possible, and the entire colon was re-examined. Polyp resection was carried out during insertion and withdrawal of the first- and second-pass examinations.
|
Procedure: Water exchange colonoscopy
During back-to-back colonoscopy, the first examination was completed with water exchange during insertion and CO2 insufflation during withdrawal. The second examination was completed with CO2 insufflation during both the insertion and withdrawal. Procedure: CO2 insufflation colonoscopy During back-to-back colonoscopy, the first examination was completed with CO2 insufflation during both the insertion and withdrawal. The second examination was also completed with CO2 insufflation during both the insertion and withdrawal. |
CO2 insufflation colonoscopy
During the first-pass colonoscopy, the procedure was performed in the usual fashion, with minimal CO2 insufflation to aid insertion. Cleaning of colon was predominantly performed during withdrawal. After the first complete withdrawal of the colonoscope, a second colonoscopic examination aided by CO2 insufflation during insertion and withdrawal was performed by the same endoscopist. The colonoscope was reinserted into the cecum as quickly as possible, and the entire colon was re-examined. Polyp resection was carried out during insertion and withdrawal of the first- and second-pass examinations.
|
Procedure: CO2 insufflation colonoscopy
During back-to-back colonoscopy, the first examination was completed with CO2 insufflation during both the insertion and withdrawal. The second examination was also completed with CO2 insufflation during both the insertion and withdrawal. |
- Percentage of Overall Detected Adenomas Missed During the First Right-Colon Colonoscopy [ Time Frame: During procedure, approximately 1.5 hours ]Right-colon (cecum, A-colon, hepatic flexure) adenomas detected on the second-pass examination were used for the calculation of adenoma miss. Adenoma miss rate was calculated as the number of adenomas missed in the first colonoscopy divided by the total number of adenomas detected during both the first and second colonoscopies.
- Percentage of Overall Detected Adenomas Missed During the First Proximal-Colon Colonoscopy [ Time Frame: During procedure, approximately 1.5 hours ]Proximal-colon (cecum, A-colon, hepatic flexure, T-colon) adenomas detected on the second-pass examination were used for the calculation of adenoma miss. Adenoma miss rate was calculated as the number of adenomas missed in the first colonoscopy divided by the total number of adenomas detected during both the first and second colonoscopies.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 20 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Consecutive patients aged 20 years or older undergoing colonoscopy for screening and surveillance indications were considered for enrollment.
Exclusion Criteria:
- familial adenomatous polyposis and hereditary non-polyposis CRC syndrome, personal history of inflammatory bowel disease, previous colonic resection, inability to achieve cecal intubation, obstructive lesions of the colon, poor colon preparation, inability to completely remove a polyp, gastrointestinal bleeding, allergy to fentanyl or midazolam, American Society of Anesthesiology classification of physical status grade 3 or higher, mental retardation, pregnancy, and refusal to provide a written informed consent.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03832322
Taiwan | |
Evergreen General Hospital | |
Taoyuan, Taiwan, 320 |
Principal Investigator: | Chi-Liang Cheng | Evergreen General Hospital, Taoyuan, Taiwan |
Documents provided by Chi-Liang Cheng, Evergreen General Hospital, Taiwan:
Responsible Party: | Chi-Liang Cheng, M.D., Evergreen General Hospital, Taiwan |
ClinicalTrials.gov Identifier: | NCT03832322 |
Other Study ID Numbers: |
EGH-2018 |
First Posted: | February 6, 2019 Key Record Dates |
Results First Posted: | May 10, 2019 |
Last Update Posted: | May 21, 2019 |
Last Verified: | May 2019 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Adenoma miss rate Adenoma detection rate |
Adenoma Neoplasms, Glandular and Epithelial Neoplasms by Histologic Type Neoplasms |